P3 Health Q2 capitated revenue $325.6M (+22% YoY); Adj EBITDA turns positive at $0.2M

P3 Health Partners Inc.

2023-Q2 EPS reported -$0.29 revenue$631,163,000

Q2 capitated revenue $325.6M (+22% YoY); medical margin $50.5M (+132%).
Adjusted EBITDA turned positive at $0.2M vs -$28.7M loss a year ago.
Net loss $27.6M vs $903.1M (prior-year loss included $851.5M goodwill impairment).
Full-year 2023 guidance: revenue $1.20-1.25B, Adj EBITDA loss $(50)-(30)M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.85

P3 Health Partners Inc. reported the three months ended June 30, 2023 results: revenue $325.6 million, net income Net loss was $27.6 million. Guidance reaffirmed.

Period: the three months ended June 30, 2023
Revenue: $325.6 million
Net income: Net loss was $27.6 million
Guidance: reaffirmed
Result: reported results

Exact text from the filing

ability to bend the cost curve for our patients, providers, and payor clients,” said Bill Bettermann, COO of P3. Second-Quarter 2023 Financial Results • Capitated revenue was $325.6 million, an increase of 21.9% compared to $267.1 million in the second quarter of the prior year • Net loss was $27.6 million, compared to a net loss of $903.1 million in the second

View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

P3 Health Partners Inc. filing history →

Source: SEC EDGAR

accession 0001628280-23-027768

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.